118 related articles for article (PubMed ID: 7607123)
1. Immunologic aspects of vigabatrin treatment in epileptic children.
Pacifici R; Zuccaro P; Iannetti P; Raucci U; Imperato C
Epilepsia; 1995 Apr; 36(4):423-6. PubMed ID: 7607123
[TBL] [Abstract][Full Text] [Related]
2. GABA changes with vigabatrin in the developing human brain.
Novotny EJ; Hyder F; Shevell M; Rothman DL
Epilepsia; 1999 Apr; 40(4):462-6. PubMed ID: 10219272
[TBL] [Abstract][Full Text] [Related]
3. [In children with refractory epilepsy: vigabatrin or lamotrigine?].
Caviedes BE; Herranz JL; Arteaga R; Armijo JA
Rev Neurol; 1999 Mar 1-15; 28(5):444-8. PubMed ID: 10229954
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin.
Guberman A
Can J Neurol Sci; 1996 Nov; 23(4 Suppl 2):S13-7. PubMed ID: 8951215
[TBL] [Abstract][Full Text] [Related]
5. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.
Petroff OA; Rothman DL; Behar KL; Mattson RH
Epilepsia; 1995 May; 36(5):457-64. PubMed ID: 7614922
[TBL] [Abstract][Full Text] [Related]
6. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
[TBL] [Abstract][Full Text] [Related]
7. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs.
Armijo JA; Cuadrado A; Bravo J; Arteaga R
Ther Drug Monit; 1997 Oct; 19(5):491-8. PubMed ID: 9357089
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.
Mattson RH; Petroff O; Rothman D; Behar K
Epilepsia; 1994; 35 Suppl 5():S29-32. PubMed ID: 8039467
[TBL] [Abstract][Full Text] [Related]
9. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
Bélanger S; Coulombe G; Carmant L
Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
[TBL] [Abstract][Full Text] [Related]
10. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy.
Dodrill CB; Arnett JL; Sommerville KW; Sussman NM
Epilepsia; 1995 Feb; 36(2):164-73. PubMed ID: 7821274
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin.
Mumford JP; Cannon DJ
Epilepsia; 1994; 35 Suppl 5():S25-8. PubMed ID: 8039466
[TBL] [Abstract][Full Text] [Related]
12. [Vigabatrin: results with a new antiepileptic agents in 57 patients in a general neurological practice].
van der Zwan A; van der Zwan A
Ned Tijdschr Geneeskd; 1994 Sep; 138(37):1859-63. PubMed ID: 7935922
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996].
De Romanis F; Sopranzi N
Clin Ter; 1998; 149(2):131-4. PubMed ID: 9780478
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic blockade ameliorates cellular immune responses to mental stress in humans.
Bachen EA; Manuck SB; Cohen S; Muldoon MF; Raible R; Herbert TB; Rabin BS
Psychosom Med; 1995; 57(4):366-72. PubMed ID: 7480566
[TBL] [Abstract][Full Text] [Related]
15. No effect of long-term vigabatrin treatment on central nervous system conduction in patients with refractory epilepsy: results of a multicenter study of somatosensory and visual evoked potentials. PMS Study Multicenter Group.
Mauguière F; Chauvel P; Dewailly J; Dousse N
Epilepsia; 1997 Mar; 38(3):301-8. PubMed ID: 9070592
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune profile of patients with advanced cancer before and after taxane treatment.
Tong AW; Seamour B; Lawson JM; Ordonez G; Vukelja S; Hyman W; Richards D; Stein L; Maples PB; Nemunaitis J
Am J Clin Oncol; 2000 Oct; 23(5):463-72. PubMed ID: 11039505
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin.
Shields WD; Sankar R
Semin Pediatr Neurol; 1997 Mar; 4(1):43-50. PubMed ID: 9097366
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
[TBL] [Abstract][Full Text] [Related]
19. Profound suppression of plasma alanine aminotransferase activity in children taking vigabatrin.
Williams A; Goldsmith R; Coakley J
Aust N Z J Med; 1994 Feb; 24(1):65. PubMed ID: 8002862
[No Abstract] [Full Text] [Related]
20. Immunologic aspects of carbamazepine treatment in epileptic patients.
Pacifici R; Paris L; Di Carlo S; Pichini S; Zuccaro P
Epilepsia; 1991; 32(1):122-7. PubMed ID: 1985820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]